Search research articles
Contact Us
Filters
Showing results (1-10 of 225) with videos related to
Page
of 23
Sort By:
Cancer Immunology Research
|
April 2, 2024
Optimal Neoantigen Cancer Vaccines Target CD8+ and CD4+ T Cells with Multiple Antigens
Craig L Slingluff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Building on the Promise of Cancer Vaccines for Solid Tumors
Craig L Slingluff
Cancer Journal (Sudbury, Mass.)
|
September 29, 2011
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
Craig L Slingluff
Current Opinion in Immunology
|
July 30, 2017
Vaccines targeting helper T cells for cancer immunotherapy
Marit Melssen, Craig L Slingluff
Journal of Translational Medicine
|
May 3, 2005
Progress and controversies in developing cancer vaccines
Craig L Slingluff, Daniel E Speiser
Journal of Surgical Oncology
|
August 5, 2009
Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera
Lynn T Dengel, Craig L Slingluff
Annals of Surgical Oncology
|
December 8, 2010
Regional control and morbidity after superficial groin dissection in melanoma
Amber L Shada, Craig L Slingluff
Journal of the National Cancer Institute
|
September 14, 2014
Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer
Anneke T Schroen, Craig L Slingluff
Statistics in Biosciences
|
June 20, 2020
Flexible Phase I-II design for partially ordered regimens with application to therapeutic cancer vaccines
Nolan A Wages, Craig L Slingluff
Vaccines
|
February 26, 2025
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials
Serena M Vilasi, Craig L Slingluff
Page
of 23
Search research articles
Search
Showing results (1-10 of 225) with videos related to
Sort By:
Page
of 23
Cancer Immunology Research
|
April 2, 2024
Optimal Neoantigen Cancer Vaccines Target CD8+ and CD4+ T Cells with Multiple Antigens
Craig L Slingluff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Building on the Promise of Cancer Vaccines for Solid Tumors
Craig L Slingluff
Cancer Journal (Sudbury, Mass.)
|
September 29, 2011
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
Craig L Slingluff
Current Opinion in Immunology
|
July 30, 2017
Vaccines targeting helper T cells for cancer immunotherapy
Marit Melssen, Craig L Slingluff
Journal of Translational Medicine
|
May 3, 2005
Progress and controversies in developing cancer vaccines
Craig L Slingluff, Daniel E Speiser
Journal of Surgical Oncology
|
August 5, 2009
Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera
Lynn T Dengel, Craig L Slingluff
Annals of Surgical Oncology
|
December 8, 2010
Regional control and morbidity after superficial groin dissection in melanoma
Amber L Shada, Craig L Slingluff
Journal of the National Cancer Institute
|
September 14, 2014
Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer
Anneke T Schroen, Craig L Slingluff
Statistics in Biosciences
|
June 20, 2020
Flexible Phase I-II design for partially ordered regimens with application to therapeutic cancer vaccines
Nolan A Wages, Craig L Slingluff
Vaccines
|
February 26, 2025
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials
Serena M Vilasi, Craig L Slingluff
Page
of 23